- Home
- PCTY vs ROIV Comparison
PCTY vs ROIV Comparison
Compare PCTY & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCTY
- ROIV
- Stock Information
- Founded
- PCTY 1997
- ROIV 2014
- Country
- PCTY United States
- ROIV United Kingdom
- Employees
- PCTY N/A
- ROIV N/A
- Industry
- PCTY Computer Software: Prepackaged Software
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- PCTY Technology
- ROIV Health Care
- Exchange
- PCTY Nasdaq
- ROIV Nasdaq
- Market Cap
- PCTY 10.5B
- ROIV 8.4B
- IPO Year
- PCTY 2014
- ROIV N/A
- Fundamental
- Price
- PCTY $194.61
- ROIV $10.64
- Analyst Decision
- PCTY Strong Buy
- ROIV Buy
- Analyst Count
- PCTY 19
- ROIV 4
- Target Price
- PCTY $223.21
- ROIV $17.50
- AVG Volume (30 Days)
- PCTY 405.7K
- ROIV 6.2M
- Earning Date
- PCTY 05-01-2025
- ROIV 05-29-2025
- Dividend Yield
- PCTY N/A
- ROIV N/A
- EPS Growth
- PCTY 16.86
- ROIV N/A
- EPS
- PCTY 4.01
- ROIV N/A
- Revenue
- PCTY $1,551,771,000.00
- ROIV $122,585,000.00
- Revenue This Year
- PCTY $13.72
- ROIV N/A
- Revenue Next Year
- PCTY $10.22
- ROIV N/A
- P/E Ratio
- PCTY $48.54
- ROIV N/A
- Revenue Growth
- PCTY 14.63
- ROIV 140.04
- 52 Week Low
- PCTY $129.94
- ROIV $8.73
- 52 Week High
- PCTY $223.80
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- PCTY 57.23
- ROIV 47.30
- Support Level
- PCTY $180.33
- ROIV $11.02
- Resistance Level
- PCTY $196.61
- ROIV $11.77
- Average True Range (ATR)
- PCTY 6.41
- ROIV 0.33
- MACD
- PCTY 0.78
- ROIV -0.02
- Stochastic Oscillator
- PCTY 87.72
- ROIV 28.93
About PCTY Paylocity Holding Corporation
Paylocity is a provider of payroll and human capital management solutions servicing small- to midsize clients in the United States. The company was founded in 1997 and targets businesses with 10-5,000 employees and services about 39,000 clients as of fiscal 2024. Alongside core payroll services, Paylocity offers HCM solutions such as time and attendance and recruiting software as well as workplace collaboration and communication tools.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.